Tonix Pharmaceuticals Holding Corp.
General ticker "TNXP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $373.9M (TTM average)
Tonix Pharmaceuticals Holding Corp. does not follow the US Stock Market performance with the rate: -4.8%.
Estimated limits based on current volatility of 2.7%: low 13.65$, high 14.40$
Factors to consider:
- Total employees count: 81 (-21.4%) as of 2024
- Top business risk factors: Cybersecurity threats, Operating losses, Regulatory and compliance, Insufficient funding, Commercialization challenges
Short-term TNXP quotes
Long-term TNXP plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.77MM | $10.09MM | $13.11MM |
| Operating Expenses | $126.15MM | $146.79MM | $138.81MM |
| Operating Income | $-118.38MM | $-136.70MM | $-125.70MM |
| Non-Operating Income | $0.00MM | $6.15MM | $1.68MM |
| Interest Expense | $0.00MM | $0.00MM | $0.09MM |
| R&D Expense | $86.66MM | $39.97MM | $44.49MM |
| Income(Loss) | $-118.38MM | $-130.55MM | $-124.02MM |
| Profit(Loss)* | $-118.38MM | $-130.55MM | $-124.02MM |
| Stockholders Equity | $105.53MM | $139.56MM | $245.15MM |
| Inventory | $14.15MM | $8.41MM | $6.01MM |
| Assets | $154.46MM | $162.89MM | $277.17MM |
| Operating Cash Flow | $-102.00MM | $-60.92MM | $-99.84MM |
| Capital expenditure | $7.89MM | $0.12MM | $3.37MM |
| Investing Cash Flow | $-29.07MM | $-0.12MM | $-4.53MM |
| Financing Cash Flow | $36.52MM | $134.87MM | $214.53MM |
| Earnings Per Share** | $-64.63 | $-57.68 | $-14.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.